Literature DB >> 3591903

Agglomeration to nodules modulates human arterial smooth muscle cells to distinct postinjury phenotype via foam cell transition.

S Björkerud.   

Abstract

Cultures of arterial smooth muscle cells (SMCs) tend to form loci with multilayered growth as "hills" or "nodules," which is unusual for normal but common for transformed cells. Earlier it was shown that such nodules were composed of SMCs with the distinctive properties of small cell size, low adhesivity, and scarce or no fibronectin and filamentous actin, features which may also characterize tumor cells. Similar properties could be induced by cultivation of SMCs in aggregates, indicating modulation of SMCs to a distinct "multilayered" phenotype, rather than selection of variant SMCs with preference for multilayered growth. Transfer of SMCs to a three-dimensional arrangement by agglomeration to nodules, "spheroids," by seeding of SMCs on low-adhesive substratum, like agarose, was followed by signs of SMC injury with focal autodigestion and with loss of material from the cells, which to some extent was deposited extracellularly, transition to foam cells with cholesterol accumulation mainly as cholesteryl esters, and eventually decrease in cell size. Identically treated fibroblasts showed similar, but much less pronounced, changes and were largely protected by whole blood serum, in contrast to SMCs. The results indicate that the "multilayered" SMC type can be conceived of as a postinjury phenotypic state which is preceded by overt cellular injury and transition to foam cells in conjunction with sudden transfer to three-dimensional arrangement in spheroids. It is suggested that similar modulation may be important in atherosclerosis, in which foam cell transition and deposition of debris are prominent changes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3591903      PMCID: PMC1899762     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Formation and disappearance of triglyceride droplets in strain L fibroblasts. An electron microscopic study.

Authors:  E E Schneeberger; R D Lynch; R P Geyer
Journal:  Exp Cell Res       Date:  1971-11       Impact factor: 3.905

2.  Reaction of the aortic wall of the rabbit after superficial, longitudinal, mechanical trauma.

Authors:  S Björkerud
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1969

3.  In vitro cultivation of rabbit aortic media and the development of the cultures in relation to cellular heterogeneity.

Authors:  S Björkerud; K Gustavsson; M Hasselgren
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1984-03

4.  In situ oxygen consumption rates of cells in V-79 multicellular spheroids during growth.

Authors:  J P Freyer; E Tustanoff; A J Franko; R M Sutherland
Journal:  J Cell Physiol       Date:  1984-01       Impact factor: 6.384

5.  Structural alterations in fibronectin correlated with morphological changes in smooth muscle cells.

Authors:  M J Brennan; A J Millis; D Mann; K E Fritz
Journal:  Dev Biol       Date:  1983-06       Impact factor: 3.582

6.  Separation of arterial smooth muscle cell subpopulations with different growth patterns.

Authors:  S Björkerud
Journal:  Acta Pathol Microbiol Immunol Scand A       Date:  1984-09

7.  Evidence for a monoclonal origin of human atherosclerotic plaques.

Authors:  E P Benditt; J M Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

8.  The relation between protein synthesis and lipide accumulation in L strain cells and Ehrlich ascites cells.

Authors:  D W KING; E L SOCOLOW; K G BENSCH
Journal:  J Biophys Biochem Cytol       Date:  1959-05-25

Review 9.  Liquid-overlay culture of cellular spheroids.

Authors:  J Carlsson; J M Yuhas
Journal:  Recent Results Cancer Res       Date:  1984

10.  The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers.

Authors:  R Ross
Journal:  J Cell Biol       Date:  1971-07       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.